1. Dehlin M, Jacobsson L, Roddy E, Sahlgrenska A, Institutionen För Medicin AFRO, Institute Of Medicine DORA, Göteborgs U, Gothenburg U, Sahlgrenska A (2020) Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nature reviews. Rheumatology 16:380–390
2. Counsell AB, Nguyen AD, Baysari MT, Kannangara DRW, McLachlan AJ, Day RO (2018) Exploring current and potential roles of Australian community pharmacists in gout management: a qualitative study. BMC Fam Pract 19:54
3. Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda J, Coyfish M, Guillo S, Jansen T, Janssens H, Liote F, Mallen CD, Nuki G, Perez-Ruiz F, Pimentao J, Punzi L, Pywell A, So AK, Tausche AK et al (2020) 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis 79:31–38
4. Liu R, Han C, Wu D, Xia X, Gu J, Guan H, Shan Z, Teng W (2015) Prevalence of Hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int 2015:1–12
5. Chen Y, Tang Z, Huang Z, Zhou W, Li Z, Li X, Sun F (2017) The prevalence of gout in mainland China from 2000 to 2016: a systematic review and meta-analysis. J Public Health-Heidelberg 25:521–529